Decision Resources' Market Access Tracker Now Covers the Middle East and Africa Market Access Tracker Analyzes the Challenges and Opportunities of Gaining and Maintaining Favorable Market Access Terms in 24 Countries
BURLINGTON, Mass., June 18, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, announces that its Market Access Tracker service now includes coverage of the Middle East and Africa. Market Access Tracker analyzes the challenges and opportunities to gaining and maintaining favorable market access terms in four international regions comprising 24 countries. The countries covered by Market Access Tracker make up the world's largest mature pharmaceutical markets, which have dominated global prescription drug sales for decades, as well as key emerging markets, which will be the main drivers of growth in the future.
In the Middle East and Africa, pharmaceutical markets vary enormously in terms of economic growth, stability and potential. According to South Africa: Market Access Tracker, South Africa is viewed as the gateway to sub-Saharan Africa, which is growing faster than the regional economies of Central and Eastern Europe, Latin America and the European Union. And although Turkey is characterized by a hostile drug pricing and cost containment landscape, Turkey: Market Access Tracker finds that the geopolitical opportunities provided from operating in Turkey and the country's goal to become a major regional player offers significant advantages to drug developers.
"Not all pharmaceutical companies will have the resources to prioritize emerging markets in the Middle East and Africa, but those that do are likely to find both opportunities and barriers," said Decision Resources Senior Director Lulu Pickering, Ph.D. "Each market presents unique characteristics; South Africa has a strong private insurance market and recent reforms there will stimulate market growth, while Turkey—along with Mexico, Indonesia and South Korea—experienced the quickest recovery from the financial crisis of 2008."
For each region covered, the Market Access Tracker service includes a web-delivered roadmap of key market access parameters, downloadable figures and tables and a robust executive summary. The service enables market research professionals to understand market access opportunities and challenges in each country and to evaluate how ongoing changes will impact their business.
Members of the media are welcome to attend our upcoming webinar entitled Market Access in the Middle East and Africa: Regional Challenges, Opportunities and Commercialization Outlook.
This webinar will be held on July 23 at 10 a.m. U.S. Eastern Time. For more information, please contact Christopher Comfort at firstname.lastname@example.org.
About Market Access Tracker
Market access is critical to a drug's commercial success, but it presents many challenges as payers are increasing prelaunch and post-marketing obstacles, causing the market access environment to be in constant flux. Market Access Tracker's timely analysis of key events in emerging and mature markets, regular webinar updates and access to our team of experts will equip biopharmaceutical companies with the insight they need to evaluate the implications of the latest changes for their business and to assess the commercial outlook in each market.
About Decision Resources
Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources Group company.
About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
SOURCE Decision Resources